VisiRose, Inc. (“VisiRose” or the “Company”), the clinical-stage ophthalmology subsidiary of Provectus Biopharmaceuticals, Inc. (“Provectus”) (OTCQB: PVCT), a clinical-stage biotechnology company ...
In two studies in retinal disease, faricimab shows improved vision and a reduced injection burden in people who switched from ...
Today sees the launch of Terminal #1 by Robert Kirkman, Joe Casey, Andy Kubert, and Dave McCaig, with David Finch and Arthur ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results